Faron Pharmaceuticals OyLSE: FARN

FARON Pharmaceuticals ltd: holding(s) in comp...

· Issued by Faron Pharmaceuticals OY via MFN

Summary by 6ix AI

Heights Capital Management, Inc. of San Francisco, California notified Faron Pharmaceuticals that its total position crossed a disclosure threshold on November 12, 2026, after an acquisition or disposal of voting rights. Its position on that date was 17.34% of voting rights, compared with 19.96% in its previous notification.

Key details

  • CVI Investments, Inc. of the Cayman Islands is named as the shareholder and appears in the chain of controlled undertakings below Heights Capital Management, Inc.
  • The 17.34% position is made up of 7.99% of voting rights attached to shares (18,215,360 voting rights) and 10.16% through financial instruments (25,760,000 voting rights from convertible bonds), for a total of 43,975,360 voting rights. The previous notification showed 8.66% and 11.30%.
  • The financial instruments are convertible bonds (debt that can be converted into shares), convertible at any time until maturity: one expiring February 8, 2027 covering 10,080,000 voting rights (3.97%), and one expiring February 12, 2028 covering 15,680,000 voting rights (6.18%).
  • Faron Pharmaceuticals, a non-UK issuer, was notified on November 13, 2026.

6ix AI wrote this summary from the release below and checked it against the release.

Faron Pharmaceuticals Ltd | Company announcement | November 17, 2026 at 15:00:00 EET

TR-1: Standard form for notification of major holdings

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i
1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii:Faron Pharmaceuticals OY
1b. Please indicate if the issuer is a non-UK issuer (please mark with an “X” if appropriate)
Non-UK issuerX
2. Reason for the notification (please mark the appropriate box or boxes with an “X”)
An acquisition or disposal of voting rightsX
An acquisition or disposal of financial instruments
An event changing the breakdown of voting rights
Other (please specify) iii:
3. Details of person subject to the notification obligation iv
NameHeights Capital Management, Inc.
City and country of registered office (if applicable)San Francisco, California
4. Full name of shareholder(s) (if different from 3.) v
NameCVI Investments, Inc.
City and country of registered office (if applicable)Cayman Islands
5. Date on which the threshold was crossed or reached vi:12/11/2026
6. Date on which issuer notified (DD/MM/YYYY):13/11/2026
7. Total positions of person(s) subject to the notification obligation
% of voting rights attached to shares (total of 8. A)% of voting rights through financial instruments
(total of 8.B 1 + 8.B 2)
Total of both in % (8.A + 8.B)Total number of voting rights held in issuer (8.A + 8.B) vii
Resulting situation on the date on which threshold was crossed or reached7.99%10.16%17.34%43,975,360
Position of previous notification (if
applicable)
8.66%11.30%19.96%
8. Notified details of the resulting situation on the date on which the threshold was crossed or reached viii
A: Voting rights attached to shares
Class/type of
shares
ISIN code (if possible)
Number of voting rights ix% of voting rights
Direct
(DTR5.1)
Indirect
(DTR5.2.1)
Direct
(DTR5.1)
Indirect
(DTR5.2.1)
18,215,36025,760,0007.99%10.16%
SUBTOTAL 8. A43,975,36017.34%
B 1: Financial Instruments according to DTR5.3.1R (1) (a)
Type of financial instrumentExpiration
date x
Exercise/
Conversion Period xi
Number of voting rights that may be acquired if the instrument is
exercised/converted.
% of voting rights
Convertible Bond08/02/2027Anytime until maturity10,080,0003.97%
Convertible Bond12/02/2028Anytime until maturity15,680,0006.18%
SUBTOTAL 8. B 125,760,00010.16%
B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)
Type of financial instrumentExpiration
date x
Exercise/
Conversion Period xi
Physical or cash
Settlement xii
Number of voting rights% of voting rights
SUBTOTAL 8.B.2
9. Information in relation to the person subject to the notification obligation (please mark the
applicable box with an “X”)
Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer xiii
Full chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary) xiv
Name xv% of voting rights if it equals or is higher than the notifiable threshold% of voting rights through financial instruments if it equals or is higher than the notifiable thresholdTotal of both if it equals or is higher than the notifiable threshold
Heights Capital Management, Inc.7.99%10.16%17.34%
CVI Investments, Inc.7.99%10.16%17.34%
10. In case of proxy voting, please identify:
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional information xvi
None
Place of completionLondon, United Kingdom
Date of completion13.11.2026

Faron Pharmaceuticals Oy on 6ix

Earlier from Faron Pharmaceuticals Oy

Later from Faron Pharmaceuticals Oy

All Faron Pharmaceuticals Oy news releases